Published in Brain on March 15, 2008
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain (2009) 2.04
Basal ganglia contributions to motor control: a vigorous tutor. Curr Opin Neurobiol (2010) 1.73
Choosing to make an effort: the role of striatum in signaling physical effort of a chosen action. J Neurophysiol (2010) 1.43
Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol (2012) 1.39
Dopamine and effort-based decision making. Front Neurosci (2011) 1.31
Medial frontal cortex motivates but does not control movement initiation in the countermanding task. J Neurosci (2010) 1.22
The brain's specialized systems for aesthetic and perceptual judgment. Eur J Neurosci (2013) 1.09
Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes. Proc Natl Acad Sci U S A (2009) 1.08
A model of reward- and effort-based optimal decision making and motor control. PLoS Comput Biol (2012) 1.08
Mechanisms of motivation-cognition interaction: challenges and opportunities. Cogn Affect Behav Neurosci (2014) 1.08
Neural mechanisms underlying paradoxical performance for monetary incentives are driven by loss aversion. Neuron (2012) 1.05
Why don't you try harder? An investigation of effort production in major depression. PLoS One (2011) 1.04
Proactive and reactive control by the medial frontal cortex. Front Neuroeng (2012) 1.01
Should I stay or should I go? Conceptual underpinnings of goal-directed actions. Front Syst Neurosci (2014) 0.98
Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism. Exp Neurol (2013) 0.97
Dopamine reverses reward insensitivity in apathy following globus pallidus lesions. Cortex (2012) 0.95
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease. Mol Psychiatry (2013) 0.90
Characterization of reward and effort mechanisms in apathy. J Physiol Paris (2014) 0.87
Impulsivity and apathy in Parkinson's disease. J Neuropsychol (2013) 0.87
Remedial effects of motivational incentive on declining cognitive control in healthy aging and Parkinson's disease. Front Aging Neurosci (2010) 0.85
Individual Differences in Premotor Brain Systems Underlie Behavioral Apathy. Cereb Cortex (2015) 0.84
Interacting outcome retrieval, anticipation, and feedback processes in the human brain. Cereb Cortex (2009) 0.82
Subthalamic nucleus local field potential activity helps encode motor effort rather than force in parkinsonism. J Neurosci (2015) 0.82
Neural correlates of motor vigour and motor urgency during exercise. Sports Med (2013) 0.80
Dopamine enhances willingness to exert effort for reward in Parkinson's disease. Cortex (2015) 0.80
Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication. J Neurol (2014) 0.80
The role of supplementary eye field in goal-directed behavior. J Physiol Paris (2015) 0.79
Harnessing motivation to alleviate neglect. Front Hum Neurosci (2013) 0.79
Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits. Transl Psychiatry (2014) 0.78
Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. Exp Neurol (2016) 0.78
Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease. Brain (2016) 0.78
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease? Transl Psychiatry (2016) 0.77
Trait Anticipatory Pleasure Predicts Effort Expenditure for Reward. PLoS One (2015) 0.77
How the brain decides when to work and when to rest: dissociation of implicit-reactive from explicit-predictive computational processes. PLoS Comput Biol (2014) 0.77
The human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-making. Brain (2016) 0.76
A selective role for right insula--basal ganglia circuits in appetitive stimulus processing. Soc Cogn Affect Neurosci (2012) 0.76
Altering Effort Costs in Parkinson's Disease with Noninvasive Cortical Stimulation. J Neurosci (2015) 0.76
Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease. Sci Rep (2017) 0.75
Computerized assessment of goal-directed behavior in Parkinson's disease. J Clin Exp Neuropsychol (2016) 0.75
Roles of Multiple Globus Pallidus Territories of Monkeys and Humans in Motivation, Cognition and Action: An Anatomical, Physiological and Pathophysiological Review. Front Neuroanat (2017) 0.75
Brain mechanisms underlying automatic and unconscious control of motor action. Front Hum Neurosci (2012) 0.75
Dissociation between mental fatigue and motivational state during prolonged mental activity. Front Behav Neurosci (2015) 0.75
Motivational modes and learning in Parkinson's disease. Soc Cogn Affect Neurosci (2014) 0.75
Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease? Front Psychiatry (2016) 0.75
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Self-terminating diffraction gates femtosecond X-ray nanocrystallography measurements. Nat Photonics (2012) 3.68
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex (2005) 2.80
Lipidic phase membrane protein serial femtosecond crystallography. Nat Methods (2012) 2.76
In vivo protein crystallization opens new routes in structural biology. Nat Methods (2012) 2.69
Direct evidence for a parietal-frontal pathway subserving spatial awareness in humans. Science (2005) 2.68
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain (2008) 2.65
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Time-resolved protein nanocrystallography using an X-ray free-electron laser. Opt Express (2012) 2.38
TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol (2009) 2.30
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
An automatic valuation system in the human brain: evidence from functional neuroimaging. Neuron (2009) 2.20
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas. Ann Neurol (2006) 2.20
Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI. Neuroradiology (2008) 2.09
Radiation damage in protein serial femtosecond crystallography using an x-ray free-electron laser. Phys Rev B Condens Matter Mater Phys (2011) 2.05
Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke (2006) 2.05
Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage (2005) 2.02
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Separate valuation subsystems for delay and effort decision costs. J Neurosci (2010) 1.97
Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage (2009) 1.95
Myoclonus-dystonia: an update. Mov Disord (2009) 1.90
Functions of the left superior frontal gyrus in humans: a lesion study. Brain (2006) 1.89
Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol (2009) 1.87
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron (2010) 1.85
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain (2008) 1.84
Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81
Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to ε-sarcoglycan mutations: a pilot study. Arch Neurol (2011) 1.79
Shining a light on posterior cortical atrophy. Alzheimers Dement (2012) 1.77
Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J (2011) 1.75
A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg (2009) 1.74
Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome. Brain (2012) 1.69
Experience of diffusion tensor imaging and 1H spectroscopy for outcome prediction in severe traumatic brain injury: Preliminary results. Crit Care Med (2009) 1.69
Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat (2007) 1.69
Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci U S A (2007) 1.66
Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology (2008) 1.64
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest (2010) 1.64
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord (2014) 1.63
Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdala: Method and validation on controls and patients with Alzheimer's disease. Neuroimage (2006) 1.60
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement (2011) 1.59
Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations. Mov Disord (2007) 1.58
Gene expression profiling of Lewy body-bearing neurons in Parkinson's disease. Exp Neurol (2005) 1.58
Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study. Lancet Neurol (2013) 1.58
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging (2011) 1.57
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord (2006) 1.54
Parkinson's disease dementia can be easily detected in routine clinical practice. Mov Disord (2010) 1.53
Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res (2006) 1.51
Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol (2006) 1.50
Effortless control: executive attention and conscious feeling of mental effort are dissociable. Neuropsychologia (2005) 1.46
Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain (2009) 1.44
Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia. J Neurol Neurosurg Psychiatry (2012) 1.44
Distinct patterns of antiamyloid-β antibodies in typical and atypical Alzheimer disease. Arch Neurol (2012) 1.44
Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J (2005) 1.44
Can we still dream when the mind is blank? Sleep and dream mentations in auto-activation deficit. Brain (2013) 1.42
Neural mechanisms underlying motivation of mental versus physical effort. PLoS Biol (2012) 1.39
Visuospatial deficits in posterior cortical atrophy: structural and functional correlates. J Neurol Neurosurg Psychiatry (2012) 1.39
Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord (2005) 1.39
Disruptive behavior as a predictor in Alzheimer disease. Arch Neurol (2007) 1.39
Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. J Neurosurg (2003) 1.35
European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry (2011) 1.33
Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. Arch Neurol (2010) 1.33
Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol (2008) 1.32
European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry (2011) 1.31
Neural correlates of cognitive impairment in posterior cortical atrophy. Brain (2011) 1.30
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain (2010) 1.30
Unsupervised classification of single-particle X-ray diffraction snapshots by spectral clustering. Opt Express (2011) 1.27
Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res (2004) 1.27
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease. Brain (2011) 1.25
Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat Neurosci (2011) 1.24
Relation between brain lesion location and clinical outcome in patients with severe traumatic brain injury: a diffusion tensor imaging study using voxel-based approaches. Hum Brain Mapp (2009) 1.24
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol (2004) 1.24
The ARUBA trial: current status, future hopes. Stroke (2010) 1.22
Riluzole in Huntington's disease: a 3-year, randomized controlled study. Ann Neurol (2007) 1.21
Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol (2008) 1.21
Oxidative stress induces senescence in chondrocytes. J Orthop Res (2011) 1.20
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol (2007) 1.20
Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clin Neurol Neurosurg (2006) 1.18
The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis (2005) 1.18
Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole. Ann Neurol (2011) 1.18
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing. J Alzheimers Dis (2013) 1.16
Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc (2005) 1.15
A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch. Curr Med Res Opin (2007) 1.15
Clinical review: Prognostic value of magnetic resonance imaging in acute brain injury and coma. Crit Care (2007) 1.14
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain (2007) 1.14
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord (2012) 1.14